Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel

B Ibanez, AH Aletras, AE Arai, H Arheden, J Bax… - Journal of the American …, 2019 - jacc.org
After a reperfused myocardial infarction (MI), dynamic tissue changes occur (edema,
inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and …

Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment

S Raj, VI Franco, SE Lipshultz - Current treatment options in …, 2014 - Springer
Opinion statement Anthracyclines have been widely used in children and adults to treat
hematologic malignancies, soft-tissue sarcomas, and solid tumors. However, anthracyclines …

Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity

C Galán-Arriola, M Lobo, JP Vílchez-Tschischke… - Journal of the American …, 2019 - jacc.org
Background: Anthracycline-induced cardiotoxicity is a major clinical problem, and early
cardiotoxicity markers are needed. Objectives: The purpose of this study was to identify early …

Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review

JM Leerink, EC de Baat, EAM Feijen, L Bellersen… - Cardio Oncology, 2020 - jacc.org
Cardiac diseases in the growing population of childhood cancer survivors are of major
concern. Cardiotoxicity as a consequence of anthracyclines and chest radiotherapy …

Anthracycline-associated T1 mapping characteristics are elevated independent of the presence of cardiovascular comorbidities in cancer survivors

JH Jordan, S Vasu, TM Morgan… - Circulation …, 2016 - Am Heart Assoc
Background—Cardiovascular magnetic resonance T1 mapping characteristics are elevated
in adult cancer survivors; however, it remains unknown whether these elevations are related …

Anthracycline therapy is associated with cardiomyocyte atrophy and preclinical manifestations of heart disease

T Ferreira de Souza, T Quinaglia AC Silva… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The goal of this study was to demonstrate that cardiac magnetic resonance could
reveal anthracycline-induced early tissue remodeling and its relation to cardiac dysfunction …

Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment

EJ Chow, KJ Leger, NS Bhatt… - Cardiovascular …, 2019 - academic.oup.com
With 5-year survival of children with cancer exceeding 80% in developed countries,
premature cardiovascular disease is now a major cause of early morbidity and mortality. In …

Cardiovascular magnetic resonance in the oncology patient

JH Jordan, RM Todd, S Vasu, WG Hundley - JACC: Cardiovascular …, 2018 - jacc.org
Patients with or receiving potentially cardiotoxic treatment for cancer are susceptible to
developing decrements in left ventricular mass, diastolic function, or systolic function. They …

Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy

MP Jolly, JH Jordan, GC Meléndez, GR McNeal… - Journal of …, 2017 - Springer
Background In patients with cancer receiving potentially cardio-toxic chemotherapy,
measurements of left ventricular (LV) circumferential or longitudinal strain are often used …

[HTML][HTML] SCMR expert consensus statement for cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease

AL Dorfman, T Geva, MM Samyn, G Greil… - Journal of …, 2022 - Elsevier
Cardiovascular magnetic resonance (CMR) is widely used for diagnostic imaging in the
pediatric population. In addition to structural congenital heart disease (CHD), for which …